Trading in the shares of Mega Genomics (HKG:6667) resumed Friday, according to a notification by the Hong Kong Stock Exchange.
Shares of the genetic testing and cancer screening services company were down over 8% in Friday afternoon trading.
The move came after the firm was able to fulfill all the resumption guidance set out by the bourse, according to a Thursday filing by the firm.
Trading in the firm's shares had previously been suspended since April 1, 2025.